NCT00363610View on ClinicalTrials.gov

A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

June 30, 2008

Conditions
TumorsLymphoma
Interventions
DRUG

Oncaspar & Gemzar; advanced and/or solid tumors and lymphoma

Trial Locations (3)

78229

Cancer Therapy & Research Center, Institute for Drug Development, San Antonio

85258

TGen Clinical Research Services at Scottsdale Healthcare, Scottsdale

68198-8511

University of Nebraska Medical Center, Omaha

Sponsors
All Listed Sponsors
lead

Enzon Pharmaceuticals, Inc.

INDUSTRY